DexCom Inc (NASDAQ:DXCM) over-valued by 41%
Website | http://www.dexcom.com |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $32,134,406,144 |
Beta | 0.751241 |
Average Volume | $800,200 |
Last Dividend | 0% |
Price on Jul 28, 2022 | $88.24 |
Autochartist™ Valuation | $51.77 |
Conclusion |
41% over-valued |
Download Report |